Pichia pastoris metabolic engineering services provide specialized solutions for optimizing the metabolic pathways of this widely used yeast species to enhance the production of valuable biochemicals, biofuels, pharmaceuticals, and other industrially relevant products. Our comprehensive services offer support from initial project design to final strain optimization, ensuring precise and efficient metabolic modifications tailored to your specific research and biotechnological needs.
Site-Specific Protein Labeling via Sortase-Mediated Transpeptidation(P Cai, et al.,2021)
Pichia pastoris, a methylotrophic yeast, is a popular system for heterologous protein expression due to its ability to grow to high cell densities and perform post-translational modifications. Our metabolic engineering services leverage advanced genetic engineering techniques, such as CRISPR/Cas9, homologous recombination, and synthetic biology approaches, to optimize the metabolic pathways of Pichia pastoris for improved production of target compounds.
The process of Pichia pastoris metabolic engineering involves several critical and interrelated steps:
For more information about our Pichia pastoris Metabolic Engineering Services or to discuss your specific needs, please contact us. Our team of experts is available to provide guidance and support for your research and biotechnological projects, ensuring you achieve your scientific and industrial goals.
The following table provides an overview of various case studies in Pichia pastoris metabolic engineering and the solutions we offer to support your research and biotechnological endeavors:
Case Study | Description | Solutions We Offer |
---|---|---|
Ethanol Production Optimization | Engineering yeast strains to enhance ethanol production from biomass. | Pathway design, genetic modification, strain optimization, and scale-up. |
Antibiotic Production Enhancement | Modifying metabolic pathways to increase the yield of antibiotics. | CRISPR/Cas9 gene editing, pathway optimization, and production scaling. |
Organic Acid Production | Developing strains for the efficient production of organic acids for industrial use. | Metabolic pathway reconstruction, strain engineering, and yield optimization. |
Industrial Enzyme Production | Engineering yeast to produce high levels of industrial enzymes. | Pathway design, strain development, and production optimization. |
Biofuel Production Strains | Optimizing metabolic pathways for the efficient production of biofuels. | Gene pathway engineering, strain development, and production optimization. |
Synthetic Pathway Construction | Constructing synthetic pathways in yeast for the production of novel biochemicals. | Synthetic biology, pathway integration, and functional assays. |
: The engineered strain overexpressing the keto-acid degradation pathway was able to produce 284 mg/L of isobutanol when supplemented with 2-ketoisovalerate. To improve the production of isobutanol and eliminate the need to supplement the production media with the expensive 2-ketoisovalerate intermediate, we overexpressed a portion of the amino acid l-valine biosynthetic pathway in the engineered strain. While heterologous expression of the pathway genes from the yeast Saccharomyces cerevisiae did not lead to improvement in isobutanol production in the engineered P. pastoris, overexpression of the endogenous l-valine biosynthetic pathway genes led to a strain that is able to produce 0.89 g/L of isobutanol. Fine-tuning the expression of bottleneck enzymes by employing an episomal plasmid-based expression system further improved the production titer of isobutanol to 2.22 g/L, a 43-fold improvement from the levels observed in the original strain. Finally, heterologous expression of a broad-substraterange alcohol-O-acyltransferase led to the production of isobutyl acetate ester and isopentyl acetate ester at 51 and 24 mg/L, respectively
Efects of diferent carbon sources on isobutanol production in engineered P. pastoris(W Siripong, et al.,2018)
Efects of diferent carbon sources on isobutanol production in engineered P. pastoris. Total isobutanol production in minimum yeast media with either 2% glycerol (a) or 2% glucose (b) as the sole carbon source. Specifc isobutanol production in minimum yeast media with either 2% glycerol (c) or 2% glucose (d) as the sole carbon source. Engineered strains (PP100, PP200, PP300) were pre-cultured in 5-mL aliquots in MGYH (2% glycerol) minimal medium overnight and used to inoculate either 5 mL fresh MGYH (2% glycerol, a, c) or 5 mL fresh MGYH_glu (2% glucose, b, d) to achieve an initial optical density of 0.05 at 600 nm (OD600). The cultures were grown at 30 °C and 250 rpm in an orbital shaking incubator. Samples were taken at 24 and 48 h time points and the supernatants were analyzed on HPLC to quantify the isobutanol content. Values are the mean of three biological replicates ± standard deviation (n = 3)
RT-PCR analysis of isobutanol biosynthetic pathway genes including PpIlv5 (a), PpIlv3 (b) PpIlv6 (c), PpIlv2 (d) in engineered yeast.(W Siripong, et al.,2018)
The engineered strains PP100, PP200, and PP300 were pre-cultured in 5-mL aliquots in MGYH (2% glycerol) minimal medium overnight and used to inoculate either 10 mL fresh MGYH (2% glycerol) to achieve an initial optical density of 0.05 at 600 nm (OD600). The cultures were grown at 30 °C and 250 rpm in an orbital shaking incubator. Samples were taken at 48 h time points for real time RT-PCR analysis
A: Pichia pastoris metabolic engineering involves the genetic modification of yeast strains to optimize their metabolic pathways for the production of target compounds. This can include introducing, deleting, or modifying specific genes to redirect metabolic fluxes and increase the yield of desired products.
A: Pichia pastoris metabolic engineering is performed through a series of steps including project consultation, pathway analysis and design, vector design and construction, yeast transformation, selection and screening, strain optimization, characterization and validation, scale-up and production, and reporting. Each step ensures precise and efficient metabolic modifications.
A: Applications include biofuel production, pharmaceutical production, industrial enzyme production, biochemicals production, synthetic biology, and agricultural biotechnology. Engineered yeast strains are used to produce valuable bioproducts and address various industrial and environmental challenges.
A: Key steps include project consultation, pathway analysis and design, vector design and construction, yeast transformation, selection and screening, strain optimization, characterization and validation, scale-up and production, and reporting. These steps ensure comprehensive and accurate development of engineered yeast strains.
A: Pichia pastoris metabolic engineering is important for advancing research, developing new bioproducts, optimizing industrial processes, and addressing environmental challenges. Engineered yeast strains provide valuable tools for enhancing production yields and creating novel compounds.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.